BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 4303881)

  • 21. Detection of acquired provirus sequences in mammary tumors from low-expressor, low-risk mice.
    Altrock BW; Cardiff RD; Puma JP; Lund JK
    J Natl Cancer Inst; 1982 Jun; 68(6):1037-41. PubMed ID: 6283224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic aspects of tumor induction by mammary tumor virus.
    Blair PB
    J Natl Cancer Inst; 1972 Apr; 48(4):1121-4. PubMed ID: 4336876
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunologic cross reactions between virus producing and non-virus producing murine mammary carcinoma].
    Zotter S; Kemmer C; Müller M; Micheel B
    Arch Geschwulstforsch; 1972; 40(1):23-34. PubMed ID: 4347235
    [No Abstract]   [Full Text] [Related]  

  • 24. An interference phenomenon associated with resistance to infection with mouse mammary tumor virus.
    Nandi S; DeOme KB
    J Natl Cancer Inst; 1965 Aug; 35(2):299-308. PubMed ID: 4283960
    [No Abstract]   [Full Text] [Related]  

  • 25. Mouse mammary tumor virus associated antigens and superantigens--immuno-molecular correlates of neoplastic progression.
    Wei WZ; Gill RF; Wang H
    Semin Cancer Biol; 1993 Jun; 4(3):205-13. PubMed ID: 8391342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunology of the mouse mammary tumor virus (MTV) : identification in vitro of mouse antibodies against MTV.
    Blair PB; Kavrin DH; Dezfulian M; Weiss DW
    Cancer Res; 1966 Apr; 26(4):647-51. PubMed ID: 4287111
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunity to a TA3 tumor subline that grows in allogeneic hosts elicited by strain-specific TA3 tumor cells.
    Lippman MM; Venditti JM; Kline I; Elam DL
    Cancer Res; 1973 Apr; 33(4):679-84. PubMed ID: 4696468
    [No Abstract]   [Full Text] [Related]  

  • 28. Tumor-specific antigen(s) in a spontaneous mammary carcinoma of C3H mice. I. Quantitative cell transplants into mammary-tumor-agent-positive and -free mice.
    Silobrcic V; Suit HD
    J Natl Cancer Inst; 1967 Dec; 39(6):1113-9. PubMed ID: 6079864
    [No Abstract]   [Full Text] [Related]  

  • 29. Accelerated growth of mammary tumor cells in normal and athymic mice after treatment in vitro with dexamethasone.
    Gillette RW; Wunderlich DA
    Cancer Res; 1978 Oct; 38(10):3146-9. PubMed ID: 80260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous occurrence of precipitating antibodies to the mammary tumor virus in mice.
    Müller M; Hageman C; Daams JH
    J Natl Cancer Inst; 1971 Oct; 47(4):801-5. PubMed ID: 4328950
    [No Abstract]   [Full Text] [Related]  

  • 31. Cellular immunity to tumor-associated antigens of transplantable mammary tumors of C3H/HeN mice.
    Tagliabue A; Herberman RB; Arthur LO; McCoy JL
    Cancer Res; 1979 Jan; 39(1):35-41. PubMed ID: 83909
    [No Abstract]   [Full Text] [Related]  

  • 32. Humoral and cellular immune responses to mouse mammary tumor virus (MMTV) in experimental animal models (review).
    Lopez DM
    Anticancer Res; 1984; 4(4-5):305-12. PubMed ID: 6091529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro studies on splenocyte cytotoxicity against syngeneic mammary carcinomas of mice. 1. Reactivity of splenocytes from mice bearing mammary tumors against the corresponding and against other neoplasms.
    More R; Yron I; Weiss DW
    Isr J Med Sci; 1978 Jan; 14(1):146-61. PubMed ID: 204609
    [No Abstract]   [Full Text] [Related]  

  • 34. Heterogeneity of expression and induction of mouse mammary tumor virus antigens in mouse mammary tumors.
    Hager JC; Heppner GH
    Cancer Res; 1982 Nov; 42(11):4325-9. PubMed ID: 6290031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
    Hager JC; Miller FR; Heppner GH
    Cancer Res; 1978 Aug; 38(8):2492-500. PubMed ID: 667845
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunology of the mouse mammary tumor virus: comparison of mammary tumor virus with the agent found in C3Hf/Crgl mice.
    Blair PB; Weiss DW
    J Natl Cancer Inst; 1966 Mar; 36(3):423-9. PubMed ID: 18630318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro detection of immune responses to MTV-induced mammary tumors: activity of spleen cell preparations from both MTV-free and MTV-infected mice.
    Blair PB; Lane MA; Yagi MJ
    J Immunol; 1974 Feb; 112(2):693-705. PubMed ID: 4360546
    [No Abstract]   [Full Text] [Related]  

  • 38. Detection of antibodies against the mammary tumor virus with the antiglobulin consumption test.
    Holmes EC; Morton DL
    J Natl Cancer Inst; 1969 May; 42(5):733-8. PubMed ID: 4306618
    [No Abstract]   [Full Text] [Related]  

  • 39. Spontaneous immunity to mammary-tumour virus (MTV)-associated antigens in mice and its influence on syngeneic mammary-tumour growth.
    Müller M; Zotter S
    Eur J Cancer (1965); 1972 Oct; 8(5):495-500. PubMed ID: 4346866
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of parabiosis on tumour growth in tumour bearing animals.
    Postuma HS
    Arch Chir Neerl; 1973; 25(3):269-82. PubMed ID: 4355262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.